August 7, 2017


Multiple Myeloma With High-Risk Features

July 2017

  • A 54-year-old Caucasian male presented to his physician with anemia
  • Bone marrow biopsy showed 43% plasma cells
  • FISH t(11:14), deletion 13, deletion 17p
  • Diagnosis: multiple myeloma with high-risk features
  • The patient was treated with lenalidomide, bortezomib, and dexamethasone (VRD) followed by autologous stem cell transplant, and bortezomib maintenance